Vir Biotechnology Inc. (VIR)
NASDAQ: VIR
· Real-Time Price · USD
4.54
0.04 (0.89%)
At close: May 15, 2025, 3:59 PM
4.52
-0.44%
After-hours: May 15, 2025, 06:35 PM EDT
Vir Biotechnology Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2019 |
|---|---|---|---|---|---|
| Collaboration Revenue Revenue | 8.38M | 37.27M | 1.51B | 917.19M | 900K |
| Collaboration Revenue Revenue Growth | -77.52% | -97.52% | +64.14% | +101810.44% | n/a |
| Contract Revenue Revenue | 55.33M | 2.23M | 52.71M | 169.87M | n/a |
| Contract Revenue Revenue Growth | +2383.53% | -95.77% | -68.97% | n/a | n/a |
| Grant Revenue | 10.49M | 46.69M | n/a | n/a | n/a |
| Grant Revenue Growth | -77.52% | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 26.7M | 25.74M | 30.27M | 36.27M | 39.09M | 41.08M | 47.1M | 46.78M | 38.74M | 43.17M | 41.59M | 38.26M | 55.78M | 50.5M | 28.78M | 25.74M | 23.04M | 18.86M | 16.39M | 12.65M | 11.81M | 9.22M | 8.01M | 8.56M | 7.95M | 7.39M | 6.89M | 6.89M |
| Selling, General, and Administrative Revenue Growth | +3.72% | -14.94% | -16.56% | -7.21% | -4.84% | -12.78% | +0.69% | +20.74% | -10.26% | +3.81% | +8.72% | -31.41% | +10.46% | +75.45% | +11.82% | +11.70% | +22.19% | +15.09% | +29.54% | +7.13% | +28.06% | +15.09% | -6.40% | +7.67% | +7.51% | +7.25% | 0.00% | n/a |
| Research and Development Revenue | 106.08M | 195.18M | 97.86M | 68.01M | 89.54M | 148.25M | 171.86M | 157.64M | 155.17M | 114.17M | 115.08M | 90.23M | 128.34M | 98.67M | 86.13M | 134.87M | 87.09M | 70.68M | 79.65M | 64.98M | 52.93M | 39.86M | 29.8M | 25.87M | 21.97M | 29.84M | 24.21M | 24.21M |
| Research and Development Revenue Growth | -45.65% | +99.44% | +43.90% | -24.04% | -39.61% | -13.74% | +9.02% | +1.59% | +35.92% | -0.80% | +27.55% | -29.70% | +30.07% | +14.56% | -36.14% | +54.85% | +23.22% | -11.26% | +22.58% | +22.76% | +32.78% | +33.75% | +15.20% | +17.74% | -26.36% | +23.25% | 0.00% | n/a |